Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Make a Bundle on $LIZ

Several funds made a bundle on Liz Claiborne, Inc. (LIZ) after it was announced Wednesday that JC Penney, Inc. (JCP) would buy the Liz Claiborne brand while Kohls Corp (KSS) would buy the Dana Buchman. According to the Wall Street Journal, the move leaves LIZ to focus on its three remaining brands – Juicy Couture, Lucky Brand Jeans, and kate spade. Stock in LIZ was up over 34% on the day. The stock had closed yesterday at $5.10 a share. It closed at $6.84 on Wednesday.  Of the funds we track, the following made the most on the news:

Ron Gutfleish

1. Tremblant Capital – Brett Barakett: Gained $14.93 million

2. Alyeska Investment Group – Anand Parekh: Gained $10.07 million

3. Elm Ridge Capital – Ron Gutfleish: Gained $5.80 million

4. Glenhill Advisors – Glenn J. Krevlin: Gained $5.72 million

5. Royce & Associates – Chuck Royce: Gained $4.49 million

6. Scopus Asset Management – Alexander Mitchell: Gained $4.43 million

7. D E Shaw – D. E. Shaw: Gained $2.83 million

8. King Street Capital – Brian J. Higgins: Gained $1.74 million

9. Millennium Management – Israel Englander: Gained $1.71 million

10. Buckingham Capital Management – David Keidan: Gained $1.38 million

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in LIZ since the end of June. We did not take into account their option positions.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!